GSK terminates collaboration with Alector after trial failures
Go back to GSK terminates collaboration with Alector after trial failures| (NASDAQ: ALEC) | Delayed: 1.50 +0.03 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.47 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.52 | P/E | N/A | |||
| Day Low | $1.42 | EPS | $ | |||
| Volume | 500,157 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.76 -1.01 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.77 | 52 Week High | $45.58 | |||
| Open | $51.07 | 52 Week Low | $37.82 | |||
| Day High | $52.27 | P/E | N/A | |||
| Day Low | $51.04 | EPS | $0.00 | |||
| Volume | 10,759,761 | |||||
